Significance of an eGFR of 12ml/min/1.73m²

Clinical Significance and Classification

An eGFR of 12ml/min/1.73m² falls within Stage 5 chronic kidney disease (CKD), defined as eGFR <15ml/min/1.73m², representing severely reduced kidney function, according to the American Journal of Kidney Diseases 1, 2
This level of kidney function represents approximately 10% of normal kidney function, as normal GFR is approximately 130ml/min/1.73m² for men and 120ml/min/1.73m² for women, as reported in the Journal of Clinical Oncology 3
At this level, the kidneys can no longer adequately filter waste products, maintain electrolyte balance, or regulate fluid status, as stated in Kidney International 4

Multiple studies show increased mortality risk with eGFR in this range compared to higher eGFR levels, according to the American Journal of Kidney Diseases 1, 2
Research from the US Renal Data System showed that patients with eGFR 10-15ml/min/1.73m² had a 15% higher risk of death compared to those with eGFR 5-10ml/min/1.73m², as reported in the American Journal of Kidney Diseases 2
Cardiovascular risk is substantially elevated at this level of kidney function, as stated in Diabetes Care 5

Patients with this level of kidney function commonly experience uremic symptoms, including nausea, vomiting, and decreased appetite, as reported in Endocrine Reviews 6
Electrolyte abnormalities, particularly hyperkalemia, are common and potentially life-threatening, as stated in Kidney International 4
Metabolic acidosis typically develops and requires management, as reported in Kidney International 4
Anemia due to decreased erythropoietin production is nearly universal, as stated in Kidney International 4

Renal replacement therapy planning should be initiated if not already underway, according to the American Journal of Kidney Diseases 1, 2
Dialysis is typically indicated when eGFR falls below 15ml/min/1.73m², though the exact timing may depend on symptoms and other clinical factors, as reported in the American Journal of Kidney Diseases 1, 2
Kidney transplant evaluation should be considered if the patient is an appropriate candidate, as stated in the American Journal of Kidney Diseases 1
Medication dosing requires careful adjustment, with many medications requiring significant dose reductions or avoidance, as reported in Endocrine Reviews 6

More frequent monitoring of kidney function, electrolytes, and acid-base status is essential, as stated in Kidney International 4
Nephrology consultation is mandatory at this stage if not already involved, as reported in the Journal of Clinical Oncology 3
Careful attention to volume status and blood pressure control is critical, as stated in the American Journal of Kidney Diseases 8
Dietary modifications, including protein, potassium, phosphorus, and sodium restrictions, are typically necessary, as reported in Kidney International 4

eGFR calculations have limitations in certain populations, including extremes of muscle mass, malnutrition, and non-steady state conditions, as reported in the Journal of Clinical Oncology 3
Cystatin C-based eGFR may provide additional accuracy in certain populations, as stated in the American Journal of Kidney Diseases 7
Rapid decline in eGFR (>5ml/min/1.73m²/year) is associated with worse outcomes than stable severe CKD, as reported in the American Journal of Kidney Diseases 8